Fingerprint
Dive into the research topics of 'Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically